Grace Capital’s Immunogen Inc IMGN Stock Holding History

Grace Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$275K	Buy	37,000 +9,000	+32%	+$55.9K	0.16%	123
2021 Q3	$164K	Hold	28,000	–	–	0.1%	159
2021 Q2	$185K	Sell	28,000 -9,000	-24%	-$62.8K	0.12%	136
2021 Q1	$300K	Sell	37,000 -1,000	-3%	-$8.16K	0.19%	130
2020 Q4	$245K	Buy	38,000 +10,000	+36%	+$58.3K	0.15%	137
2020 Q3	$100K	Sell	28,000 -21,500	-43%	-$86.8K	0.08%	177
2020 Q2	$228K	Hold	49,500	–	–	0.2%	111
2020 Q1	$169K	Sell	49,500 -12,000	-20%	-$52.5K	0.17%	107
2019 Q4	$314K	Hold	61,500	–	–	0.26%	100
2019 Q3	$149K	Sell	61,500 -10,000	-14%	-$26.6K	0.15%	114
2019 Q2	$155K	Buy	71,500 +12,000	+20%	+$28.4K	0.07%	156
2019 Q1	$161K	Sell	59,500 -9,000	-13%	-$39K	0.06%	170
2018 Q4	$329K	Buy	68,500 +29,000	+73%	+$176K	0.15%	140
2018 Q3	$375K	Hold	39,500	–	–	0.15%	126
2018 Q2	$384K	Buy	+39,500	New	+$416K	0.15%	135

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Grace Capital's IMGN Position: Q4 2021 in Review

Grace Capital increased its Immunogen Inc (IMGN) stake by 32% in Q4 2021, buying an estimated $55.9K and bringing the position to 37,000 shares worth $275K. The position accounts for 0.16% of the portfolio, ranked #123.

Grace Capital first reported a position in IMGN in Q2 2018 and has held it in 15 quarters since. The position peaked at $384K in Q2 2018. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Grace Capital held 37,000 shares of Immunogen Inc worth $275K as of Q4 2021.
Grace Capital bought 9,000 Immunogen Inc shares in Q4 2021, an estimated $55.9K.
Immunogen Inc made up 0.16% of Grace Capital's portfolio in Q4 2021, its #123 holding.
Grace Capital first reported a position in Immunogen Inc in Q2 2018 and has held it in 15 quarters since.
Grace Capital's Immunogen Inc position peaked at $384K in Q2 2018.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.